Adjuvant Palbociclib in HR+/HER2 Early Breast Cancer - Final results from PALLAS Trial

Dana-Farber's Erica Mayer, MD, MPH discusses the final analysis of the International Phase 3 PALLAS clinical trial presented at the 2021 San Antonio Breast Cancer Symposium.

Related Presenters

Erica Mayer, MD, MPH.

Erica Mayer, MD, MPH

Institute Physician
Assistant Professor of Medicine, Harvard Medical School

Dr. Mayer received her medical degree from Harvard Medical School in 2000. She subsequently completed her residency in Internal Medicine at Brigham and Women's Hospital, and her fellowship in Medical Oncology at Dana-Farber Cancer Institute. ...

View full profile


Related Videos